Entity

Time filter

Source Type

Ramat Gan, Israel

Patent
Epix Pharmaceuticals Inc. and Amgen | Date: 2011-12-16

The present invention relates to amides that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulators, e.g., for treating or preventing diseases such as autoimmune and related immune disorders including systemic lupus erythematosus, inflammatory bowel diseases such as Crohns disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, non-glomerular nephrosis, hepatitis, Behets disease, glomerulonephritis, chronic thrombocytopenic purpura, hemolytic anemia, hepatitis and Wegners granuloma; and for treating other conditions.


Patent
Epix Pharmaceuticals Inc. | Date: 2010-08-24

The present invention relates to compounds that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. In certain embodiments, the compounds of the invention relate to aryl oxoimidazolidinyls.


Trademark
EPIX Pharmaceuticals Inc. | Date: 2008-03-10

PHARMACEUTICALS AND THERAPEUTICS FOR USE IN CONNECTION WITH ONCOLOGY AND FOR USE IN DETECTING AND/OR TREATING VASCULAR AND CARDIOVASCULAR DISEASE, PERIPHERAL OCCLUSIVE DISEASE, BREAST CANCER, FEMALE SEXUAL AROUSAL DYSFUNCTION, ATHEROSCLEROSIS AND MYOCARDIAL PERFUSION, VENOUS THROMBOSIS, PULMONARY EMBOLISM AND BLOOD CLOTS; MEDICAL IMAGING CONTRAST AGENTS AND MAGNETIC RESONANCE IMAGING AGENTS.


Trademark
Epix Pharmaceuticals Inc. and Epix Medical Inc. | Date: 2008-11-25

Pharmaceuticals and therapeutics for use in connection with oncology and for detecting, monitoring and treating cardiovascular disease. Medical research; research and development of pharmaceuticals and therapeutics.


Trademark
EPIX Pharmaceuticals Inc. | Date: 2007-11-28

PHARMACEUTICALS AND THERAPEUTICS FOR USE IN DETECTING AND/OR TREATING VASCULAR DISEASE, PERIPHERAL OCCLUSIVE DISEASE, BREAST CANCER, FEMALE SEXUAL AROUSAL DYSFUNCTION, ATHEROSCLEROSIS AND MYOCARDIAL PERFUSION, VENOUS THROMBOSIS, PULMONARY EMBOLISM AND BLOOD CLOTS; MEDICAL IMAGING CONTRAST AGENTS AND MAGNETIC RESONANCE IMAGING AGENTS. LICENSING TECHNOLOGY TO OTHERS IN THE FIELD OF MEDICAL IMAGING CONTRAST AGENTS AND MAGNETIC RESONANCE IMAGING AGENTS. MEDICAL RESEARCH; RESEARCH AND DEVELOPMENT OF MEDICAL IMAGING CONTRAST AGENTS AND MAGNETIC RESONANCE IMAGING AGENTS.

Discover hidden collaborations